Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Previous studies have suggested that ovarian hormones may provide protective effects on cardiovascular diseases (CVD). Surgical removal of the uterus (hysterectomy) is a common surgery performed particularly among pre-menopausal women. However, this affects ovarian function and may lead to early onset of ovarian failure. Hysterectomy with further removal of both ovaries (hysterectomy with bilateral oophorectomy) is sometimes also performed as a prophylactic procedure and can lead to a surgical menopause. The relationship between these procedures on CVD risk in women is uncertain, particularly in Chinese women where the burden of CVD is higher than in Western countries. In a recent study published in Stroke using data from the China Kadoorie Biobank (CKB), researchers investigated the differences between treatment for CVD provided to men and women in China. 

Using data from CKB, the study found evidence that both proceedures were significantly associated with a greater risk of ischemic stroke and ischaemic heart disease, particularly if the procedure had been performed at an earlier age. Women who had undergone surgery before the age of 48 compared to those who had it later were found to have 8% and 24% higher risk of ischaemic stroke for hysterectomy only and hysterectomy plus oophorectomy respectively.

These findings suggest that women, especially those who undergo these procedures earlier in life, may benefit from additional screening for risk factors of CVD to help prevent disease onset. These risks should also be considered when advising women on the possible adverse effects of surgery, particularly when deciding whether to remove or conserve the ovaries in women who require a hysterectomy.

Latest news

Carbon monoxide linked to lower Parkinson’s risk, opening potential new treatment pathway

Study links higher carbon monoxide levels to lower Parkinson’s risk, pointing to a potential new pathway for future treatments.

New study highlights importance of heart disease treatments targeting both cholesterol and inflammation

Study identifies 12 proteins that could lead to new heart disease treatments targeting both cholesterol and inflammation.

Professor Zhengming Chen awarded major European Research Council Advanced Grant

Zhengming Chen receives ERC Advanced Grant for research exploring obesity, metabolic disease and health across diverse populations.